Analystreport

Alder Biopharmaceuticals Inc (NASDAQ: ALDR) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $29.00 price target on the stock.

ALDER BIOPHARMACEUTICALS INC  (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806